Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Valsatril Versus Entresto in Healthy Subjects
NCT07746908Phase 1Completed
- Sponsor
- Center for Bioequivalence Studies and Clinical Research
- Start
- Feb 2025
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sacubitril and valsartan in heart failure (HF) (2 arms), sponsored by Center for Bioequivalence Studies and Clinical Research. Primary endpoints: Area Under the Curve and Maximum Plasma Concentration. Started Feb 2025; status: completed.
02
Drugs
sacubitrilvalsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07746908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746908.